113 related articles for article (PubMed ID: 36999190)
21. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study.
Acuti Martellucci C; Nomura S; Yoneoka D; Ueda P; Brotherton J; Canfell K; Palmer M; Manzoli L; Giorgi Rossi P; De Togni A; Palmonari C; Califano A; Saito E; Hashizume M; Shibuya K
BJOG; 2021 Feb; 128(3):532-539. PubMed ID: 32779381
[TBL] [Abstract][Full Text] [Related]
23. Association between mothers' screening uptake and daughters' HPV vaccination: a quasi-experimental study on the effect of an active invitation campaign.
Venturelli F; Baldacchini F; Campari C; Perilli C; Pascucci MG; Finarelli AC; Moscara L; Rossi PG
BMJ Open; 2017 Sep; 7(9):e016189. PubMed ID: 28951407
[TBL] [Abstract][Full Text] [Related]
24. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
[TBL] [Abstract][Full Text] [Related]
25. Association between human papillomavirus vaccine uptake and cervical cancer screening in the Netherlands: implications for future impact on prevention.
Steens A; Wielders CC; Bogaards JA; Boshuizen HC; de Greeff SC; de Melker HE
Int J Cancer; 2013 Feb; 132(4):932-43. PubMed ID: 22689326
[TBL] [Abstract][Full Text] [Related]
26. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
[TBL] [Abstract][Full Text] [Related]
27. Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference.
Giorgi Rossi P; Carozzi F; Federici A; Ronco G; Zappa M; Franceschi S;
Prev Med; 2017 May; 98():21-30. PubMed ID: 27894910
[TBL] [Abstract][Full Text] [Related]
28. The impact of bivalent HPV vaccine on cervical intraepithelial neoplasia by deprivation in Scotland: reducing the gap.
Cameron RL; Kavanagh K; Cameron Watt D; Robertson C; Cuschieri K; Ahmed S; Pollock KG
J Epidemiol Community Health; 2017 Oct; 71(10):954-960. PubMed ID: 28756395
[TBL] [Abstract][Full Text] [Related]
29. Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results.
Castle PE; Xie X; Xue X; Poitras NE; Lorey TS; Kinney WK; Wentzensen N; Strickler HD; Burger EA; Schiffman M
Prev Med; 2019 Jan; 118():44-50. PubMed ID: 30316878
[TBL] [Abstract][Full Text] [Related]
30. Does the HPV vaccination programme have implications for cervical screening programmes in the UK?
Beer H; Hibbitts S; Brophy S; Rahman MA; Waller J; Paranjothy S
Vaccine; 2014 Apr; 32(16):1828-33. PubMed ID: 24530938
[TBL] [Abstract][Full Text] [Related]
31. Non-Adherence To Childhood HPV Vaccination Is Associated With Non-Participation In Cervical Cancer Screening
Badre-Esfahani S; Larsen MB; Seibæk L; Petersen LK; Blaakær J; Støvring H; Andersen B
Clin Epidemiol; 2019; 11():969-980. PubMed ID: 31814770
[TBL] [Abstract][Full Text] [Related]
32. Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study.
Jansen EEL; de Kok IMCM; Kaljouw S; Demirel E; de Koning HJ; Hontelez JAC
BMC Med; 2022 Nov; 20(1):433. PubMed ID: 36352410
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
34. The Differential Risk of Cervical Cancer in HPV-Vaccinated and -Unvaccinated Women: A Mathematical Modeling Study.
Naslazi E; Hontelez JAC; Naber SK; van Ballegooijen M; de Kok IMCM
Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):912-919. PubMed ID: 33837119
[TBL] [Abstract][Full Text] [Related]
35. Effects of numerical information on intention to participate in cervical screening among women offered HPV vaccination: a randomised study.
Hestbech MS; Gyrd-Hansen D; Kragstrup J; Siersma V; Brodersen J
Scand J Prim Health Care; 2016 Dec; 34(4):401-419. PubMed ID: 27845597
[TBL] [Abstract][Full Text] [Related]
36. Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands.
Schurink-van 't Klooster TM; Siebers AG; Hoes J; van Kemenade FJ; Berkhof J; Bogaards JA; de Melker HE
Cancer Med; 2023 May; 12(10):11786-11794. PubMed ID: 36965085
[TBL] [Abstract][Full Text] [Related]
37. Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer.
Kjaer SK; Dehlendorff C; Belmonte F; Baandrup L
J Natl Cancer Inst; 2021 Oct; 113(10):1329-1335. PubMed ID: 33876216
[TBL] [Abstract][Full Text] [Related]
38. [Results and cost evaluation of triage with high risk HPV test in cervical cancer screening. A pilot study in Piedmont (North-West Italy)].
Magnani C; Gillio Tos A; De Marco L; Calvia M; Cipelletti A; Bestagini P; Pagano E; Segnan N; Ronco G
Epidemiol Prev; 2012; 36(2):88-94. PubMed ID: 22706358
[TBL] [Abstract][Full Text] [Related]
39. Sexual behavior, clinical outcomes and attendance of cervical cancer screening by HPV vaccinated and unvaccinated sexually active women.
Sauvageau C; Gilca V; Ouakki M; Kiely M; Coutlée F; Mathieu-Chartier S; Defay F; Lambert G
Hum Vaccin Immunother; 2021 Nov; 17(11):4393-4396. PubMed ID: 34410872
[TBL] [Abstract][Full Text] [Related]
40. Real-world effectiveness of HPV vaccination against cervical neoplasia among birth cohorts ineligible for routine vaccination.
Dong L; Nygård M; Støer NC; Klungsøyr O; Hansen BT
Int J Cancer; 2023 Jul; 153(2):399-406. PubMed ID: 36866965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
